Company Overview and News
American Express Co. (NYSE: AXP) is scheduled to release its most recent quarterly results after the markets close on Wednesday. The consensus estimates from Thomson Reuters are $1.82 in earnings per share (EPS) on $10.05 billion in revenue. The second quarter of last year reportedly had EPS of $1.47 and $8.31 billion in revenue.
Amazon.com, Visa Inc., Apple Inc., Alibaba Group Holdings, and Microsoft are the largest five individual stock positions.
UNLNF HSB SCGLF LLOBF ABLZF CSCO UBS.PRDCL TCTZF GE COF-P VOD SCGLY PBR DDAIF AAWW 500180 MSFT NTES RIO WST AXP LEN.B COF-D COF-C COF-F HEI RTNTF ACA FAF BIDU HBCYF HCS.PRB ASML UL VOD UN BHPBF LLY GSK 0005 HDB GNE BHP 8035 TV SSYS VRNT AZN VALE3 MS.PRE FCX MS.PRF MS.PRG SIVB MS.PRA TOELY 6506 6503 VSH PEGA TOELF SMG SLB SMSN VECO PFIZER HCS HEI.A MS.PRI CFRUY MS.PRK RJD SCL SLB PFE RJF SMSD JD COF.PRG HD COF.PRH SSNLF SMFG COF.PRP UBS DG HDFCBANK COF.PRC HSBC COF.PRD ABEV SF.PRA COF.PRF SNN LFUS COST COF MRAAY LECO TORO SNY V PEP VODPF MRK MRAAF LLD5 SU LLD7 LLD6 LLD1 DPZ LLD2 INGR RIO BLT ULVR BECN YASKY SAN SAM AMX MS TSM YASKF INFY UTX BABA NVO JNJ LLDTF NVS BHPLF AZPN BAP LEN WMGI CFRHF RTPPF CLGX BOE AAPL INTC BBVA KBH POOL LLOY ITUB CRARF TTC LLPH ING SAP LLPK MEL LLPJ LLPE JPM LLPD LLPG HSEA HSEB LLPC CRARY 500680 ULSGF SMCAY BCS XOM CTRP COF.WS SEM WMT AMZN TCEHY ASML UNLYF SF BC94 BBD STE BRK.A GOOGL RIO BBL GLE BA EWBC PG NTCT YELP GOOG HRC CHE ASX HSBC.PRA ORCL QRVO PFZ BUD GEC MIELF SFN LYG UMPQ ABB VALE BHP MIELY CVX OCLCF SFB
American Express has made numerous attempts to breakout above my annual pivot of $109.17 since January but has been unable to do so.
American Express Co. (NYSE: AXP) began testing a blockchain version of its customer rewards program in May and is now going one step deeper into blockchain development with a patent application related to a proof of payment (PoP) system. The idea behind the system is to provide better evidence of payment transactions between merchants and their customers.
Earnings reporting season for the second quarter has gotten underway, and 24/7 Wall St. has put together a preview of the Dow Jones industrial average companies scheduled to report their quarterly results this week. Seven of the index’s 30 components are expected to share their results this week. The Dow has been subject to incredible volatility since January, but potentially this earnings season could stabilize the index.
GS.PRB GS.PRA AXP GS GLSSP IBM JBK GEC GE TRV GSC GS.PRICL TFG GSJ GS.PRJ GS.PRI JNJ GS.PRD GS.PRC TRI GNE MSFT GJS GS.PRN UNH GS.PRK
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning.
KMI.WS ECOR PLNT KMI.PRA PKG AEP NINE ADT GE COF-P GILD TMUS PDYPF SYF XERS JNJ VZ MSFT ADS KZR NNN EIDX FB RF.PRB AVRO RF.PRA HOPE NFLX AXP EHC BAC COF-D SEAS COF-C COF-F KR KS IIIV PNFP AAPL DDOC AEP.PRA SJM INPAP SIX JPM GNE WRK LGEJY KMRFZ DE 39IB KMX COF.WS RF UAL WMT CFIN LGEAF IP AMZN MGTA NTRS HON KMI CIWV GM.WS.A GM.WS.B HCSG GM.WS.C KMR CVB VLKAY LGEIY EBAY EPRT STT SLB BAC DFS LGEPF STM BBY BX BK STM LTXB LGLD SLB GM.WSB FOXA CLW COF.PRG COF.PRH PM STT.PRC STT.PRE NTRSP STT.PRD STT.PRG AUTL COF.PRP DLPH SWKS GS SWK TRTX GM PII COF.PRC COF.PRD DIS NEE COF.PRF IBM MOR F GEC C CMCSA COF FUN FUL CFG HBAN NEE.PRI XEL NEE.PRJ TGT BLK S PPG T NEE.PRC NEE.PRQ NEE.PRR SNE DPZ
After a sparkling 2017, many of the top bank and financial institution stocks have sputtered in 2018, and with the economy improving and the prospects for interest rates to go higher, the sector may be offering investors some of the best opportunities. Another positive for the industry has been tax reform, which appears to be helping to improve credit quality, which is a huge metric for financial institutions as they are often the lenders of first choice for consumers.
COF.PRG COF.PRH COF-P SLMBP SLMAP COF.WS COF.PRP AXP COF SLM COF-D COF-C COF-F ALLY.PRA ALLY OSM COF.PRC COF.PRD ISM JSM COF.PRF
If you have any passing interest in bitcoin, you’ll know that the virtual-currency market has seen better days. The original blockchain-reward token fell worryingly below the $6,000 mark recently, setting fears about additional selloffs. That said, I believe the current juncture offers a shrewd opportunity to consider alternative cryptocurrencies to buy.
BNC BABA EFX AXP MSFT SANT SAN INTC SAN
June 29, 2018: Markets opened higher Friday and held on to early gains as the closing bell draws near. Financial stocks rallied following the Fed’s announcement on stress tests and the banks’ promises to return cash to shareholders, even if one of the banks got a good break. Every sector traded higher in the late afternoon led by energy and materials.
NKE XOM AXP INTC
Since losing its exclusive business with Costco back in 2016, American Express Co. (NYSE: AXP) has struggled to regain its spending volume. Between the second and third quarters of 2016, Amex volume dropped by $20 billion and the company fell behind Mastercard Inc. (NYSE: MA) into third place behind volume leader Visa Inc. (NYSE: V).
V AMZN MA AXP
Believe it or not, not every stock was trashed on Monday. Campbell Soup (NYSE:CPB) managed a 9% advance on the heels or reports that rival Kraft Heinz (NASDAQ:KHC) was planning to make an acquisition offer.
BAC MMC CPB KHC AXP NFLX NYTAB HOG
2018-07-17 - Asif
History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...
2018-07-17 - Asif
Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...
2018-07-16 - Asif
General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...
Silicon Investor Message Boards
This table lists all message boards related to AXP / American Express Co. on message board site Silicon Investor.
as of ET